SEI Medical PCL

SEI Medical PCL EBIT

The EBIT of SEI Medical PCL (SEI.BK) as of Oct 30, 2026 is 57.51 M THB. In the previous year, EBIT was 65.21 M THB — a change of -11.81% (lower).

EBIT

57.51 MTHB

YoY

-11.81%

Last updated:

In 2025, SEI Medical PCL's EBIT was 57.51 M THB, a -11.81% increase from the 65.21 M THB EBIT recorded in the previous year.

The SEI Medical PCL EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT
Date
EBIT
Jan 1, 2022
23.27 M THB
Jan 1, 2023
29.93 M THB
Jan 1, 2024
65.21 M THB
Jan 1, 2025
57.51 M THB
Jan 1, 2026 (e)
0.00 THB
Jan 1, 2027 (e)
0.00 THB
The SEI Medical PCL EBIT history
YEAREBITYoY
est0.00THB—
est0.00THB-100.00%
57.51 MTHB-11.81%
65.21 MTHB+117.86%
29.93 MTHB+28.63%
23.27 MTHB—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

SEI Medical PCL Revenue

SEI Medical PCL Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
317.77 M THB
23.27 M THB
17.86 M THB
Jan 1, 2023
390.28 M THB
29.93 M THB
21.87 M THB
Jan 1, 2024
440.64 M THB
65.21 M THB
52.23 M THB
Jan 1, 2025
447.52 M THB
57.51 M THB
46.50 M THB
Jan 1, 2026 (e)
0.00 THB
0.00 THB
71.40 M THB
Jan 1, 2027 (e)
0.00 THB
0.00 THB
0.00 THB

SEI Medical PCL Margins

SEI Medical PCL stock margins

The SEI Medical PCL margin analysis displays the gross margin, EBIT margin, as well as the profit margin of SEI Medical PCL. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for SEI Medical PCL.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
31.92 %
7.32 %
5.62 %
Jan 1, 2023
29.80 %
7.67 %
5.60 %
Jan 1, 2024
35.02 %
14.80 %
11.85 %
Jan 1, 2025
34.92 %
12.85 %
10.39 %
Jan 1, 2026 (e)
34.92 %
0.00 %
- %
Jan 1, 2027 (e)
34.92 %
0.00 %
0.00 %

SEI Medical PCL Stock analysis

What does SEI Medical PCL do? SEI Medical PCL generates revenue through the distribution and leasing of medical equipment and laboratory instruments. The company's primary products include endoscopy equipment, surgical equipment, aesthetic equipment, neonatal care equipment, and laboratory equipment, sold across its Scientific equipment and medical equipment segments. Service contracts form another key revenue stream, covering maintenance and support for medical devices. The firm serves healthcare providers and institutions requiring diagnostic and treatment solutions, leveraging its Bangkok headquarters to operate within Thailand's medical sector. The company's business model focuses on selling scientific and medical equipment, offering service contracts, and providing medical equipment lease agreements. Its segments are clearly defined as Scientific equipment and medical equipment, with service as a separate offering. Revenue is derived from direct sales to hospitals, clinics, and laboratories, as well as from long-term lease contracts. The firm's IPO on September 24, 2024, marks its entry into public markets, though it continues to rely on its established distribution network for growth. SEI Medical PCL's core operations involve the sale of specialized medical equipment including endoscopy, surgical, and neonatal care devices, alongside laboratory instruments. The service segment provides essential maintenance and technical support, enhancing customer retention. The company targets healthcare facilities seeking comprehensive solutions for diagnostic and therapeutic procedures, positioning itself as a key supplier in Thailand's medical equipment market. SEI Medical PCL is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing SEI Medical PCL's EBIT

SEI Medical PCL's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of SEI Medical PCL's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

SEI Medical PCL's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in SEI Medical PCL’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about SEI Medical PCL stock

EBIT of SEI Medical PCL is 57.51 M THB in 2025.

EBIT of SEI Medical PCL changed from 65.21 M THB to 57.51 M THB, representing a -11.81% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT SEI Medical PCL since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's SEI Medical PCL historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — SEI Medical PCL

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — SEI Medical PCL